Using a combination of human neural stem cells and 3K3A-APC, a recombinant variant of human activated protein C, researchers have been able to dramatically increase the production of nerve cells in mice with stroke-induced brain damage. The findings were reported on 22 August 2016 in Nature Medicine.
